Neurology Minute
1,924 episodes — Page 8 of 39
Women History Minute - Maria Mikhaĭlovna Manàsseina
Dr. Alison Christy delves into another women's history minute to discuss Maria Mikhaĭlovna Manàsseina.
Women History Minute - Ana Judith Roman Garcia
Dr. Alison Christy delves into another women's history minute to discuss the first female neurologist in Puerto Rico - Ana Judith Roman Garcia.
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma - Part 2
In part two of a two-part series, Dr. Justin Abbatemarco and Dr. Nicolás Lundahl Ciano-Petersen discuss the associated paraneoplastic syndromes they saw from a neurologic perspective. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200260
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma - Part 1
In part one of a two-part series, Dr. Justin Abbatemarco and Dr. Nicolás Lundahl Ciano-Petersen break down Merkel cell carcinoma and discuss what all neurologists need to know about it. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200260
Using Design Thinking to Understand the Reason for Headache Referrals
Dr. Tesha Monteith and Dr. Ashish D. Patel discuss headache referrals and the implementation of a design thinking approach to improve access to headache care. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200336
Lab Minutes - Paraneoplastic Lab
In this lab minute, Dr. Stacey Clardy talks about paraneoplastic panels.
Lab Minutes - Myasthenia Gravis Lab
Dr. Stacey Clardy discusses when to test for myasthenia gravis in this lab minute.
Lab Minutes - IgG vs. IgM
Dr. Stacey Clardy discusses the fundamentals of the immune response to infection and explains how to accurately distinguish between past and current or recent infections.
Clinical Implementation of fMRI and EEG to Detect CMD
Dr. Neha Dangayach and Drs. Yelena Bodien and Brian Edlow discuss the concept of cognitive motor dissociation (CMD) in neurocritical care, highlighting its implications for patient assessment and treatment. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200390
2024 Guideline for the Primary Prevention of Stroke - Part 5
In the final episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss major takeaways from the new guidelines for the primary prevention of stroke. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
2024 Guideline for the Primary Prevention of Stroke - Part 4
In the fourth episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss stroke prevention in pregnancy. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
Empowering Health Care Providers
Dr. Andy Southerland and Dr. Scott Friedenberg discuss the significant challenge of financial health within a department or practice, and how it impacts patient and provider satisfaction as well as clinical habits. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200314
2024 Guideline for the Primary Prevention of Stroke - Part 3
In the third episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss the dietary recommendations outlined in the guidelines for primary stroke prevention. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
Disparities in Utilization of Outpatient Telemedicine for Neurologic Care
Dr. Shuvro Roy and Dr. Marisa Patryce McGinley discuss outpatient telemedicine utilization for neurologic conditions and identify potential disparities. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200407
2024 Guideline for the Primary Prevention of Stroke - Part 2
In the second episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss the recommendations for patients with high-risk antiphospholipid profile and the increased risk of stroke. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
2024 Guideline for the Primary Prevention of Stroke - Part 1
In the first episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss notable changes in the guidelines compared to previous versions, including the introduction of endometriosis as an inflammatory condition that has been shown to increase the risk of stroke. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
Artificial Intelligence in Residency Recruitment - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Drs. Rachel Gottlieb-Smith and Kathryn Xixis discuss the potential dangers or pitfalls of using AI to help review residency applications. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200150
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how clinicians should approach serological antibody testing in patients with REM behavior disorder or other associated neurologic symptoms. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200311
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how frequently the IGLON5 antibody is identified among patients with idiopathic REM behavior disorder. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200311
Artificial Intelligence in Residency Recruitment - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Drs. Rachel Gottlieb-Smith and Kathryn Xixis discuss the potential advantages that the increasing accessibility of artificial intelligence presents for the identification and recruitment of the next generation of neurologists. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200150
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 3
In the third part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the best strategies to enhance EEG education in child neurology and neurodevelopmental disability programs. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 2
In the second part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the current state of EEG education in child neurology and neurodevelopmental disability programs, focusing on EEG rotation characteristics and resident evaluations. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 1
In the first part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the significance of this publication and the objectives their team aimed to achieve with the study. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
Central Mechanisms of Cough and Their Neurologic Implications
Dr. Derek Stitt and Dr. Reece Hass discuss the neuroanatomy of the cough reflex, the relationship between cough and pain, and specific neurological conditions that can lead to neurogenic cough. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000210064
Medical Forecasting - Part 2
In the second part of this two-part series, Dr. Justin Abbatemarco and Drs. Claire J. Creutzfeldt and Robert G. Holloway discuss how medical forecasting can assist in answering questions that patients or family members often ask. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820194
Medical Forecasting - Part 1
In part one of this two-part series, Dr. Justin Abbatemarco and Drs. Claire J. Creutzfeldt and Robert G. Holloway discuss understanding medical forecasting. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820194
Understanding Amyloidosis
In this episode of Neurology Minute, Dr. Stacey Clardy discusses Amyloidosis. Show reference: https://doi.org/10.1111/imj.15974
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 2
In the second part of this two-part series, Dr. Stacey Clardy and Dr. Bhooma R. Aravamuthan talk about the future of the diagnostic label for cerebral palsy. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200353
Distinguishing Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer Disease
Dr. Vikram Karnik and Dr. Kate Wyman-Chick discuss distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease and the implications for clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200380
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 1
In the first part of this two-part series, Dr. Stacey Clardy and Dr. Bhooma R. Aravamuthan discuss the current definition of cerebral palsy and the appropriate diagnostic labeling in clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200353
CMS Releases Final 2025 Physician Fee Schedule - Part 3
In part three of this three-part series, Dr. Jason Crowell and Max Goldman discuss potential legislative actions affecting the 2025 Medicare Physician Fee Schedule. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule
CMS Releases Final 2025 Physician Fee Schedule - Part 2
In part two of this three-part series, Dr. Jason Crowell and Matt Kerschner explores advancements and challenges in telehealth services for 2025. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule
CMS Releases Final 2025 Physician Fee Schedule - Part 1
In part one of this three-part series, Dr. Jason Crowell and Matt Kerschner discuss the key updates and changes to the Medicare Physician Fee Schedule for 2025. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule
Understanding Acute Symptomatic Seizures
Dr. Halley Alexander and Dr. Vineet Punia discuss factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2824063
Features of Educational Social Media Posts - Part 2
In the second episode of this two-part series, Dr. Stacey Clardy and Dr. Catherine Albin discuss the differences between traditional educational methods and the innovative use of social media for teaching. Show references: https://www.neurology.org/doi/10.1212/NE9.0000000000200160
Features of Educational Social Media Posts - Part 1
In the first episode of this two-part series, Dr. Stacey Clardy and Dr, Catherine Albin discuss the key features of educational social media posts that drive high sharing and engagement. Show references: https://www.neurology.org/doi/10.1212/NE9.0000000000200160
Hereditary Ataxia SCA27B
Dr. Vikram Karnak discusses the novel hereditary ataxia SCA27b, its genetic basis, symptoms, and potential treatments, emphasizing the need for testing in unexplained adult-onset ataxia.
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
In part two of this two-part series, Dr. Justin Abbatemarco and Dr. Maarten Titulaer discuss the link between HSV and NMDAR encephalitis and how that impacts longitudinal recovery. Show reference: https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000210109
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
In part two of this two-part series, Dr. Justin Abbatemarco and Dr. Maarten Titulaer discuss the link between HSV and NMDAR encephalitis and how that impacts longitudinal recovery. Show reference: https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000210109
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 1
In part one of this two-part series, Dr. Justin Abbatemarco and Dr. Maarten Titulaer discuss long-term cognitive and functional outcomes in patients with anti-NMDAR encephalitis and their implications for rehabilitation. Show reference: https://www.neurology.org/doi/pdf/10.1212/WNL.0000000000210109
Myelitis Associated With Rheumatologic Disease - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Elias Sotirchos discuss abandoning the term lupus myelitis and emphasize the importance of accurately naming and identifying each autoimmune condition. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200329
Myelitis Associated With Rheumatologic Disease - Part 1
In part one of this two-part series, Dr. Stacey Clardy and Dr. Elias Sotirchos discuss key features of inflammatory myelopathy in rheumatologic disease, helping to better characterize the underlying causes of lupus myelitis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200329
Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?
Dr. Tesha Monteith discusses the Brain & Life article, "Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?" by Hallie Levine, available in the latest issue of Brain & Life or at brainandlife.org. Show reference: https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how to differentiate between CAA-RI and PACNS. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
The Placebo Effect
Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548
Lab Minute - Vitamin D
Dr. Stacey Clardy discusses vitamin D in this lab minute.
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading
Dr. Halley Alexander discusses the Neurology Today article, "Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading" by Gina Shaw, available in the November 7th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2024&issue=11070&article=00001&type=Fulltext
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457